Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
crispr
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech
boston top stories
cancer
eli lilly
fda
gilead sciences
glaxosmithkline
multiple myeloma
sanofi
startups
allergan
alzheimer's disease
What
bio
roundup
companies
month
new
acquisitions
announced
approval
biogen’s
biopharma
biopharmaceutical
black
ceo
collabs
congress
congressional
continue
convo
covid
crispr
daniel
deal
debut
diamond
diamond’s
drug
earlier
executives
failures
feud
gilead
gilead’s
group
help
indication
introduce
ipo
isn’t
known
later
Language
unset
Current search:
crispr
×
" raleigh-durham top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More